Broadfin Capital, LLC Buys NanoString Technologies Inc, Xenon Pharmaceuticals Inc, La Jolla Pharmaceutical Co, Sells Mirati Therapeutics Inc, Endo International PLC, Exact Sciences Corp

• New Purchases: NSTG, XENE, XENT, ANGO, IDRA, ALNY, TSRO, DXCM, KALV, VRAY,
• Added Positions: LJPC, IOVA, PACB, ADMA, SRRA, QTNT, IART, ZGNX, SLGL, SBBP,
• Reduced Positions: MRTX, HZNP, CORI, HRTX, CPRX, KALA, RTRX, ADMS, LIVN, SSKN,
• Sold Out: ENDP, EXAS, XRAY, MTD, XERS, GBT, MDWD, ODT,

For the details of Broadfin Capital, LLC's stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=Broadfin+Capital%2C+LLC

1. iShares Russell 2000 (IWM) - 400,000 shares, 9.97% of the total portfolio.
2. Iovance Biotherapeutics Inc (IOVA) - 4,894,361 shares, 8.14% of the total portfolio. Shares added by 18.03%
3. La Jolla Pharmaceutical Co (LJPC) - 2,053,991 shares, 6.12% of the total portfolio. Shares added by 37.43%
4. Zogenix Inc (ZGNX) - 657,898 shares, 4.83% of the total portfolio. Shares added by 5.71%
5. ADMA Biologics Inc (ADMA) - 4,463,829 shares, 4.1% of the total portfolio. Shares added by 37.36%

Broadfin Capital, LLC initiated holding in NanoString Technologies Inc. The purchase prices were between $11.36 and $18.21, with an estimated average price of $14.61. The stock is now traded at around $15.66. The impact to a portfolio due to this purchase was 2.24%. The holding were 850,000 shares as of 2018-09-30.

Broadfin Capital, LLC initiated holding in Xenon Pharmaceuticals Inc. The purchase prices were between $9 and $14.9, with an estimated average price of $11.58. The stock is now traded at around $8.49. The impact to a portfolio due to this purchase was 1.75%. The holding were 895,553 shares as of 2018-09-30.

Broadfin Capital, LLC initiated holding in Intersect ENT Inc. The purchase prices were between $26.05 and $36.6, with an estimated average price of $30.11. The stock is now traded at around $30.50. The impact to a portfolio due to this purchase was 1%. The holding were 234,200 shares as of 2018-09-30.

Broadfin Capital, LLC initiated holding in AngioDynamics Inc. The purchase prices were between $18.95 and $24.23, with an estimated average price of $22.22. The stock is now traded at around $19.50. The impact to a portfolio due to this purchase was 0.93%. The holding were 289,035 shares as of 2018-09-30.

Broadfin Capital, LLC initiated holding in Idera Pharmaceuticals Inc. The purchase prices were between $5.53 and $11.36, with an estimated average price of $8.47. The stock is now traded at around $7.75. The impact to a portfolio due to this purchase was 0.83%. The holding were 629,340 shares as of 2018-09-30.

Broadfin Capital, LLC initiated holding in Alnylam Pharmaceuticals Inc. The purchase prices were between $87.52 and $122.67, with an estimated average price of $100.59. The stock is now traded at around $68.32. The impact to a portfolio due to this purchase was 0.81%. The holding were 62,200 shares as of 2018-09-30.

Broadfin Capital, LLC added to a holding in La Jolla Pharmaceutical Co by 37.43%. The purchase prices were between $20.13 and $34.02, with an estimated average price of $26.12. The stock is now traded at around $15.19. The impact to a portfolio due to this purchase was 1.67%. The holding were 2,053,991 shares as of 2018-09-30.

Broadfin Capital, LLC added to a holding in Pacific Biosciences of California Inc by 136.51%. The purchase prices were between $3.52 and $5.55, with an estimated average price of $4.29. The stock is now traded at around $7.69. The impact to a portfolio due to this purchase was 1.15%. The holding were 2,493,021 shares as of 2018-09-30.

Broadfin Capital, LLC added to a holding in ADMA Biologics Inc by 37.36%. The purchase prices were between $4.39 and $6.85, with an estimated average price of $5.75. The stock is now traded at around $5.11. The impact to a portfolio due to this purchase was 1.12%. The holding were 4,463,829 shares as of 2018-09-30.

Broadfin Capital, LLC added to a holding in Sierra Oncology Inc by 94.17%. The purchase prices were between $1.7 and $3.08, with an estimated average price of $2.27. The stock is now traded at around $1.66. The impact to a portfolio due to this purchase was 0.5%. The holding were 4,090,344 shares as of 2018-09-30.

Broadfin Capital, LLC added to a holding in Quotient Ltd by 83.01%. The purchase prices were between $6.57 and $8.31, with an estimated average price of $7.51. The stock is now traded at around $6.24. The impact to a portfolio due to this purchase was 0.41%. The holding were 804,700 shares as of 2018-09-30.

Broadfin Capital, LLC added to a holding in Integra Lifesciences Holdings Corp by 20.28%. The purchase prices were between $57.63 and $65.87, with an estimated average price of $62.11. The stock is now traded at around $52.78. The impact to a portfolio due to this purchase was 0.32%. The holding were 196,572 shares as of 2018-09-30.

Broadfin Capital, LLC sold out a holding in Endo International PLC. The sale prices were between $9.77 and $17.15, with an estimated average price of $14.18.

Broadfin Capital, LLC sold out a holding in Exact Sciences Corp. The sale prices were between $48.29 and $80.6, with an estimated average price of $65.21.

Broadfin Capital, LLC sold out a holding in Dentsply Sirona Inc. The sale prices were between $37.45 and $48.44, with an estimated average price of $41.66.

Broadfin Capital, LLC sold out a holding in Mettler-Toledo International Inc. The sale prices were between $559.44 and $617.94, with an estimated average price of $588.21.

Broadfin Capital, LLC sold out a holding in Xeris Pharmaceuticals Inc. The sale prices were between $17.58 and $27.23, with an estimated average price of $21.71.

Broadfin Capital, LLC sold out a holding in Global Blood Therapeutics Inc. The sale prices were between $38 and $51.1, with an estimated average price of $44.38.